http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4092425-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-811 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate | 1977-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1978-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e53fca4ef1578620797f7dae301d78a |
| publicationDate | 1978-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-4092425-A |
| titleOfInvention | Restoration of interferon response |
| abstract | The present invention provides a method for treatment of hyporeactivity to interferon induction in interferon producing animals or animal cells which comprises administering a hyporeactive interferon stimulating prostaglandin (HIS-PG) to an interferon producing animal or animal cells having a hyporeactive (decreased) interferon response. Hyporeactive interferon stimulating prostaglandins (HIS-PG) refers to those prostaglandin-type compounds which are useful in alleviating the decreased ability of interferon producing animals or animal cells to produce interferon following administration of repeated doses of an interferon inducer or as a consequence of viral infection or neoplasia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6824762-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4871772-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5015481-A |
| priorityDate | 1977-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.